TABLE 2

Effect of 5-HT (100 μM) and the mGlu2/3/8 receptor antagonist LY341495 on EPSC frequency (number/s) and amplitude (pA)

All of the values displayed are means ± S.E.


LY341495

n

Basal

5-HT

LY341495

5-HT/LY341495
EPSC frequency
    100 nM 10 3.9 ± 0.7 32.1 ± 6.0 3.5 ± 0.9 35.8 ± 7.4
    1 μM 11 4.4 ± 1.0 32.8 ± 5.3 3.6 ± 0.9 45.8 ± 5.6a
    10 μM 11 4.4 ± 0.9 20.0 ± 2.5 5.5 ± 1.7 33.9 ± 4.2a
    30 μM 9 3.3 ± 0.8 22.5 ± 3.7 3.2 ± 0.9 35.3 ± 4.9a
EPSC amplitude
    100 nM 10 65.4 ± 3.0 81.8 ± 5.3 62.6 ± 5.2 83.9 ± 6.0
    1 μM 11 51.8 ± 3.3 74.2 ± 5.0 54.6 ± 3.9 83.7 ± 6.4a
    10 μM 11 63.7 ± 4.9 78.5 ± 4.1 65.7 ± 4.7 98.6 ± 4.4a
    30 μM
9
64.8 ± 3.1
80.3 ± 3.3
63.5 ± 4.8
96.2 ± 6.0a
  • a p < 0.001 compared with respective control (e.g., 5-HT versus 5-HT/LY341495).